Assessment of the Lowest Effective Dose of Dexmedetomidine in Attenuating the Hemodynamic Responses During Skull Pin Insertion in Patients Undergoing Elective Craniotomy: Randomized Control Study
Phase of Trial: Phase 0
Latest Information Update: 20 Nov 2018
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Adverse reactions
- 20 Nov 2018 New trial record
- 09 Nov 2018 Planned initiation date changed from 1 Dec 2018 to 15 Nov 2018.
- 09 Nov 2018 Status changed from not yet recruiting to recruiting.